Stratos Wealth Partners LTD. acquired a new stake in shares of Albemarle Corporation (NYSE:ALB) during the third quarter, according to its most recent filing with the SEC. The fund acquired 1,639 shares of the specialty chemicals company’s stock, valued at approximately $223,000.

Other large investors also recently added to or reduced their stakes in the company. Thompson Davis & CO. Inc. raised its stake in shares of Albemarle Corporation by 650.0% during the 3rd quarter. Thompson Davis & CO. Inc. now owns 750 shares of the specialty chemicals company’s stock valued at $102,000 after purchasing an additional 650 shares during the period. Northwestern Mutual Wealth Management Co. raised its stake in shares of Albemarle Corporation by 2.1% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 968 shares of the specialty chemicals company’s stock valued at $102,000 after purchasing an additional 20 shares during the period. Carroll Financial Associates Inc. raised its stake in shares of Albemarle Corporation by 0.3% during the 2nd quarter. Carroll Financial Associates Inc. now owns 982 shares of the specialty chemicals company’s stock valued at $103,000 after purchasing an additional 3 shares during the period. Highlander Capital Management LLC bought a new stake in shares of Albemarle Corporation during the 2nd quarter valued at $106,000. Finally, Smithfield Trust Co. raised its stake in shares of Albemarle Corporation by 16.1% during the 2nd quarter. Smithfield Trust Co. now owns 1,008 shares of the specialty chemicals company’s stock valued at $106,000 after purchasing an additional 140 shares during the period. Institutional investors own 87.10% of the company’s stock.

WARNING: This report was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another domain, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this report can be accessed at https://www.watchlistnews.com/1639-shares-in-albemarle-corporation-alb-purchased-by-stratos-wealth-partners-ltd/1717684.html.

A number of analysts recently issued reports on ALB shares. BidaskClub lowered Albemarle Corporation from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. Loop Capital started coverage on Albemarle Corporation in a research note on Thursday, September 28th. They set a “buy” rating and a $150.00 price objective on the stock. Royal Bank Of Canada reiterated a “buy” rating and set a $149.00 price objective on shares of Albemarle Corporation in a research note on Wednesday, October 18th. KeyCorp reiterated a “buy” rating and set a $125.00 price objective on shares of Albemarle Corporation in a research note on Sunday, September 3rd. Finally, Nomura upped their target price on Albemarle Corporation from $146.00 to $154.00 and gave the stock a “buy” rating in a research note on Tuesday, October 10th. Nine analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $128.45.

Albemarle Corporation (NYSE:ALB) opened at $136.48 on Tuesday. Albemarle Corporation has a fifty-two week low of $82.58 and a fifty-two week high of $144.99. The company has a quick ratio of 1.56, a current ratio of 2.11 and a debt-to-equity ratio of 0.35. The stock has a market capitalization of $14,960.00, a PE ratio of 33.72, a PEG ratio of 2.07 and a beta of 1.72.

Albemarle Corporation (NYSE:ALB) last posted its quarterly earnings data on Wednesday, November 8th. The specialty chemicals company reported $1.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.01. Albemarle Corporation had a return on equity of 11.61% and a net margin of 30.07%. The firm had revenue of $755.00 million during the quarter, compared to analysts’ expectations of $732.19 million. During the same period in the prior year, the business earned $0.91 EPS. The company’s revenue for the quarter was up 15.4% compared to the same quarter last year. research analysts anticipate that Albemarle Corporation will post 4.46 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 2nd. Stockholders of record on Friday, December 15th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.94%. The ex-dividend date of this dividend is Thursday, December 14th. Albemarle Corporation’s payout ratio is currently 45.71%.

In other news, EVP Matthew Juneau sold 5,397 shares of the company’s stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $115.77, for a total value of $624,810.69. Following the completion of the transaction, the executive vice president now directly owns 360 shares in the company, valued at approximately $41,677.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Karen G. Narwold sold 11,500 shares of the stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $115.95, for a total value of $1,333,425.00. Following the sale, the executive vice president now owns 36,620 shares of the company’s stock, valued at $4,246,089. The disclosure for this sale can be found here. 0.74% of the stock is currently owned by corporate insiders.

Albemarle Corporation Company Profile

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Corporation (NYSE:ALB).

Institutional Ownership by Quarter for Albemarle Corporation (NYSE:ALB)

Receive News & Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.